Sumitomo Mitsui Trust Holdings, Inc. Organon & Co. Transaction History

Sumitomo Mitsui Trust Holdings, Inc.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 30, 2023	SELL	$16.59 - $23.77 $1.17 Million - $1.67 Million	-70,355 Reduced 76.47%	21,648 $375,000
Q2 2023 Jul 31, 2023	BUY	$19.27 - $24.63 $257,524 - $329,155	13,364 Added 16.99%	92,003 $1.91 Million
Q1 2023 Apr 27, 2023	BUY	$21.42 - $32.08 $2,698 - $4,042	126 Added 0.16%	78,639 $1.85 Million
Q4 2022 Jan 30, 2023	SELL	$23.31 - $28.61 $22,424 - $27,522	-962 Reduced 1.21%	78,513 $2.19 Million
Q3 2022 Oct 21, 2022	SELL	$23.4 - $34.25 $311,196 - $455,490	-13,299 Reduced 14.33%	79,475 $1.86 Million
Q2 2022 Jul 26, 2022	BUY	$31.66 - $38.9 $2.94 Million - $3.61 Million	92,774 New	92,774 $3.13 Million
Q1 2022 Apr 27, 2022	SELL	$30.45 - $39.36 $2.52 Million - $3.26 Million	-82,894 Closed	0 $0
Q4 2021 Feb 02, 2022	BUY	$28.67 - $37.13 $142,489 - $184,536	4,970 Added 6.38%	82,894 $2.52 Million
Q3 2021 Oct 25, 2021	SELL	$28.63 - $35.64 $383,584 - $477,504	-13,398 Reduced 14.67%	77,924 $2.56 Million
Q2 2021 Aug 02, 2021	BUY	$28.45 - $38.0 $2.6 Million - $3.47 Million	91,322 New	91,322 $2.76 Million

790

201M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $4.17B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Sumitomo Mitsui Trust Holdings, Inc., based on Form 13F filings with the SEC.

Stay updated on Sumitomo Mitsui Trust Holdings, Inc. with notifications on news.